To include your compound in the COVID-19 Resource Center, submit it here.

Esperion raises $151.9M for CVOT

Esperion Therapeutics Inc. (NASDAQ:ESPR) raised $151.9 million late Wednesday through the sale

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE